Product Information

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB is a generic product labeled by Mylan Institutional LLC, priced at $0.4960 per EA under NDC 42292001720. Its NADAC has been published 468 times since Sep 6, 2017.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB

spironolactone and hydrochlorothiazide
$0.4960per EA

Strength

25; 25 mg/1; mg/1

NDC

42292001720

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA086513

FDA Approved

Before 1982

TE Code

AB

On Market Since

5/12/2017

Pharmacological Classes

Aldosterone Antagonist
Aldosterone Antagonists
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has been published 468 times since Sep 6, 2017, and over the history we have for it it has declined 48.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4960 per EA
All-time high$0.9563 (Sep 13, 2017)
All-time low$0.3906 (Nov 20, 2024)
52-week high$0.5749
52-week low$0.4960
Median price$0.6692
Average price$0.6782
Largest weekly change+37.7% (Aug 21, 2024)
Weeks tracked468
Tracking sinceSep 6, 2017

Price History

1W

-3.7%

1M

-3.7%

3M

-7.2%

6M

-4.4%

1Y

-13.7%

3Y

-14.6%

5Y

-27.5%

All

-48.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

The current National Average Drug Acquisition Cost (NADAC) for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB, manufactured by Mylan Institutional LLC, is $0.4960 per EA (NDC 42292001720), effective Aug 19, 2026.

How has the price of SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB changed over time?

Over the history we have for it, the NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has declined 48.1%. It has been tracked across 468 weekly CMS publications since Sep 6, 2017.

What are the highest and lowest recorded NADAC prices for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

Since Sep 6, 2017, the NADAC for SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB has ranged from a low of $0.3906 (Nov 20, 2024) to a high of $0.9563 (Sep 13, 2017), with a median of $0.6692 per EA.

Are there cheaper alternatives to SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB?

SPIRONOLACTONE-HYDROCHLOROTHIAZIDE 25-25 TAB (NDC 42292001720) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.